Gopinathan Suma

SVP, DiscoveryLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2026Option exercise(M)66K174K
Feb 28, 2026Tax withholding(F)24K$1.47$36K150K
Feb 28, 2026Option exercise(M)20K109K
Feb 28, 2026Option exercise(M)14K89K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2026Option exercise(M)14K0
Feb 28, 2026Option exercise(M)20K20K
Feb 28, 2026Option exercise(M)66K131K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000038) within minutes of acceptance. Every field above traces to the original document. Verify it directly: